iProgen Biotech Inc.
$600,000.00 CAD
≈ 8 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- December 1, 2021 – December 31, 2023
- Reference
- nrc-cnrc:172-2021-2022-Q4-984807
Published purpose
This is part of a CIIP Korea project. It will support the firm to generate a series of novel Antibody Oligo Conjugate (AOC) candidates that target lucrative but untapped therapeutic opportunities, by combining two different biotechnologies: 1) Antibody Drug Conjugate and 2) Oligo Therapeutics. The AOC candidates will be evaluated against important multidimensional variables for successful clinical deployment, including biological activity, stability, ease of production and pharmacokinetics.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions